Prosecution Insights
Last updated: April 19, 2026

Examiner: LY, KRISTINA ELISABETH

Tech Center 1600 • Art Units: 1671

This examiner grants 100% of resolved cases

Performance Statistics

100.0%
Allow Rate
+40.0% vs TC avg
20
Total Applications
+100.0%
Interview Lift
1175
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

11.2%
§101 Eligibility
21.4%
§102 Novelty
22.5%
§103 Obviousness
37.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18378412 PHAGE FOR LYSING BURKHOLDERIA GLADIOLI AND USE THEREOF Non-Final OA Hefei University of Technology
18257820 METHOD OF PRODUCING A RECOMBINANT VIRUS PARTICLE Non-Final OA REGENXBIO INC.
18363520 METHOD FOR SELECTING ANTIGENIC VIRAL SEQUENCES FOR VACCINES AND THERAPEUTICS Non-Final OA THE CURATORS OF THE UNIVERSITY OF MISSOURI
18283937 MEMBRANE FILTRATION APPARATUS, CONCENTRATION APPARATUS, AND CONCENTRATION METHOD Non-Final OA Yokogawa Electric Corporation
18278775 NOVEL BACTERIOPHAGE HAVING ABILITY TO SPECIFICALLY KILL CLOSTRIDIUM PERFRINGENS AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME Non-Final OA CJ CheilJedang Corporation
18030714 METHOD FOR DETERMINING PRESENCE/ABSENCE OF NOROVIRUS INFECTION RISK Non-Final OA Denka Company Limited
18253624 Human Papilloma Virus Vaccines and Uses of the Same for HPV Associated Diseases Non-Final OA PRECIGEN, INC.
18556556 RHABDOVIRUS-NEGATIVE SPODOPTERA FRUGIPERDA INSECT CELL LINE, AND SCREENING, IDENTIFICATION AND APPLICATION THEREOF Non-Final OA WestVac Biopharma Co., Ltd.
18473468 MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS Non-Final OA Seqirus UK Limited
18264965 IMMUNOLOGICAL TEST FOR THE DETECTION OF VIRAL INFECTIONS Non-Final OA BIOSPEEDIA
18365533 QUALITATIVE, MULTIPLEX REVERSE TRANSCRIPTION PCR FOR THE DIFFERENTIAL DETECTION OF THE ORTHOPOX VIRUS MONKEYPOX Non-Final OA RenegadeXBio, PBC
18273158 METHODS FOR DIAGNOSIS AND TREATMENT OF COVID-19 Non-Final OA MARSHALL UNIVERSITY RESEARCH CORPORATION
18039472 STABLE LENTIVIRUS PACKAGING CELL LINE AND PREPARATION METHOD THEREFOR Non-Final OA BEIJING YIMIAOYILIAO CO., LTD.
18325281 MODIFIED VACCINE DESIGN DEVELOPMENTS Non-Final OA VLP Therapeutics Japan, INC.
18137786 METHOD FOR ATTENUATING INFLUENZA VIRUS BY SYNONYMOUS MUTATION AND DELETION MUTATION, AND ATTENUATED INFLUENZA VIRUS STRAIN AND USE Non-Final OA Zhejiang Difference Biological Technology Co., Ltd.
18185056 ANTIBODY FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND USES THEREOF Non-Final OA NOVASCOPE BIOCHIPS INC.
18185141 ANTIBODY FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND USES THEREOF Non-Final OA NOVASCOPE BIOCHIPS INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month